{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:28:24Z","timestamp":1786577304555,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-026-01154-w","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:16:11Z","timestamp":1780474571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunoinformatics-guided design of a multi-epitope vaccine targeting WISP1 for gastric cancer"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8386-774X","authenticated-orcid":false,"given":"Negar","family":"Mottaghi-Dastjerdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0903-2960","authenticated-orcid":false,"given":"Behzad","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4669-0708","authenticated-orcid":false,"given":"Khadijeh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-1140","authenticated-orcid":false,"given":"Mohammad","family":"Soltany-Rezaee-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"3","key":"1154_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clinicians"},{"issue":"4","key":"1154_CR2","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.bj.2024.100817","volume":"48","author":"J-T Hsu","year":"2025","unstructured":"Hsu J-T, Lin Y-N, Chen Y-F, Kou H-W, Wang S-Y, Chou W-C, et al. A comprehensive overview of gastric cancer management from a surgical point of view. Biomed J. 2025;48(4):100817. https:\/\/doi.org\/10.1016\/j.bj.2024.100817.","journal-title":"Biomed J"},{"issue":"9","key":"1154_CR3","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.3390\/biomedicines12092158","volume":"12","author":"R Ghemrawi","year":"2024","unstructured":"Ghemrawi R, Abuamer L, Kremesh S, Hussien G, Ahmed R, Mousa W, et al. Revolutionizing cancer treatment: recent advances in immunotherapy. Biomedicines. 2024;12(9):2158. https:\/\/doi.org\/10.3390\/biomedicines12092158.","journal-title":"Biomedicines"},{"issue":"1","key":"1154_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.22038\/ijbms.2017.25686.6335","volume":"21","author":"E Gheybi","year":"2018","unstructured":"Gheybi E, Salmanian AH, Fooladi AAI, Salimian J, Hosseini HM, Halabian R, et al. Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice. Iran J Basic Med Sci. 2018;21(1):26\u201332. https:\/\/doi.org\/10.22038\/ijbms.2017.25686.6335.","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"1154_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3892\/ijmm.2024.5388","volume":"54","author":"N Sueangoen","year":"2024","unstructured":"Sueangoen N, Thuwajit P, Yenchitsomanus P-T, Thuwajit C. Public neoantigens in breast cancer immunotherapy (review). Int J Mol Med. 2024;54(1):65. https:\/\/doi.org\/10.3892\/ijmm.2024.5388.","journal-title":"Int J Mol Med"},{"key":"1154_CR6","doi-asserted-by":"publisher","first-page":"101324","DOI":"10.1016\/j.mam.2024.101324","volume":"101","author":"F Ruzzi","year":"2025","unstructured":"Ruzzi F, Riccardo F, Conti L, Tarone L, Semprini MS, Bolli E, et al. Cancer vaccines: Target antigens, vaccine platforms and preclinical models. Mol Aspects Med. 2025;101:101324. https:\/\/doi.org\/10.1016\/j.mam.2024.101324.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"1154_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s12672-024-01459-2","volume":"15","author":"H Chen","year":"2024","unstructured":"Chen H, Zhang X, Zhang Z, Li G, Li X, Yang S, et al. Identification and validation of CCN family genes to predict the prognosis in gastric cancer. Discov Oncol. 2024;15(1):610. https:\/\/doi.org\/10.1007\/s12672-024-01459-2.","journal-title":"Discov Oncol"},{"issue":"38","key":"1154_CR8","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.3748\/wjg.v25.i38.5814","volume":"25","author":"LH Zhang","year":"2019","unstructured":"Zhang LH, Wang Y, Fan QQ, Liu YK, Li LH, Qi XW, et al. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer. WJG. 2019;25(38):5814\u201325. https:\/\/doi.org\/10.3748\/wjg.v25.i38.5814.","journal-title":"WJG"},{"key":"1154_CR9","doi-asserted-by":"publisher","unstructured":"Gaudreau P-O, Clairefond S, Class CA, Boulay P-L, Chrobak P, Allard B, et al. WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors. OncoImmunology. 2019;8(5):e1581545. https:\/\/doi.org\/10.1080\/2162402X.2019.1581545.","DOI":"10.1080\/2162402X.2019.1581545"},{"issue":"1","key":"1154_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12672-024-01225-4","volume":"15","author":"F Khoshdel","year":"2024","unstructured":"Khoshdel F, Mottaghi-Dastjerdi N, Yazdani F, Salehi S, Ghorbani A, Montazeri H, et al. CTGF, FN1, IL-6, THBS1, and WISP1 genes and PI3K-Akt signaling pathway as prognostic and therapeutic targets in gastric cancer identified by gene network modeling. Discov Onc. 2024;15(1):344. https:\/\/doi.org\/10.1007\/s12672-024-01225-4.","journal-title":"Discov Onc"},{"issue":"9","key":"1154_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.cmet.2022.07.009","volume":"34","author":"Y Xi","year":"2022","unstructured":"Xi Y, LaCanna R, Ma HY, N\u2019Diaye EN, Gierke S, Caplazi P, et al. A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis. Cell Metab. 2022;34(9):1377\u201393.e8. https:\/\/doi.org\/10.1016\/j.cmet.2022.07.009.","journal-title":"Cell Metab"},{"issue":"3","key":"1154_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/acsabm.1c01238","volume":"5","author":"IW Hamley","year":"2022","unstructured":"Hamley IW. Peptides for vaccine development. ACS Appl Bio Mater. 2022;5(3):905\u201344. https:\/\/doi.org\/10.1021\/acsabm.1c01238.","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"1154_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12967-024-05364-8","volume":"22","author":"K Singh","year":"2024","unstructured":"Singh K, Oladipupo SS. An overview of CCN4 (WISP1) role in human diseases. J Transl Med. 2024;22(1):601. https:\/\/doi.org\/10.1186\/s12967-024-05364-8.","journal-title":"J Transl Med"},{"issue":"3","key":"1154_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1080\/07391102.2021.2020166","volume":"41","author":"SAH Mohammadzadeh Hosseini Moghri","year":"2023","unstructured":"Mohammadzadeh Hosseini Moghri SAH, Mahmoodi Chalbatani G, Ranjbar M, Raposo C, Abbasian A. CD171 multi-epitope peptide design based on immuno-informatics approach as a cancer vaccine candidate for glioblastoma. J Educ Chang Biomol Struct Dyn. 2023;41(3):1028\u201340. https:\/\/doi.org\/10.1080\/07391102.2021.2020166.","journal-title":"J Educ Chang Biomol Struct Dyn"},{"issue":"16","key":"1154_CR15","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1080\/07391102.2022.2123395","volume":"41","author":"SAH Mohammadzadeh Hosseini Moghri","year":"2023","unstructured":"Mohammadzadeh Hosseini Moghri SAH, Ranjbar M, Hassannia H, Khakdan F. In silico analysis of the conserved surface-exposed epitopes to design novel multiepitope peptide vaccine for all variants of the SARS-CoV-2. J Educ Chang Biomol Struct Dyn. 2023;41(16):7603\u201315. https:\/\/doi.org\/10.1080\/07391102.2022.2123395.","journal-title":"J Educ Chang Biomol Struct Dyn"},{"key":"1154_CR16","doi-asserted-by":"publisher","first-page":"111100","DOI":"10.1016\/j.compbiomed.2025.111100","volume":"197","author":"A Khalaj","year":"2025","unstructured":"Khalaj A, Moghri M. Immunoinformatics design of multi-epitope vaccine candidates against \u201cESKAPE\u201d pathogens as nosocomial infection. Comput Biol Med. 2025;197:111100. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111100.","journal-title":"Comput Biol Med"},{"key":"1154_CR17","doi-asserted-by":"publisher","first-page":"102086","DOI":"10.1016\/j.bbrep.2025.102086","volume":"43","author":"N Rahimi-Farsi","year":"2025","unstructured":"Rahimi-Farsi N, Shahbazi T, Ghorbani A, Mottaghi-Dastjerdi N, Yazdani F, Mohseni P, et al. Network-based analysis of candidate oncogenes and pathways in hepatocellular carcinoma. Biochem Biophys Rep. 2025;43:102086. https:\/\/doi.org\/10.1016\/j.bbrep.2025.102086.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"1154_CR18","doi-asserted-by":"publisher","first-page":"100471","DOI":"10.1016\/j.jgeb.2025.100471","volume":"23","author":"N Rahimi-Farsi","year":"2025","unstructured":"Rahimi-Farsi N, Ghorbani A, Mottaghi-Dastjerdi N, Shahbazi T, Bostanian F, Mohseni P, et al. Comprehensive systems biology analysis of microRNA-101-3p regulatory network identifies crucial genes and pathways in hepatocellular carcinoma. J Genet Eng Biotechnol. 2025;23(1):100471. https:\/\/doi.org\/10.1016\/j.jgeb.2025.100471.","journal-title":"J Genet Eng Biotechnol"},{"key":"1154_CR19","doi-asserted-by":"publisher","unstructured":"Rahimi H, Farzadifar E, Mottaghi-Dastjerdi N, Ghorbani A, Amerizadeh F, Pasdar A. Integrative systems biology analysis of MicroRNA regulation in Wnt signaling pathway during breast cancer progression. Int J Cancer Manag. 2025;18(1):e164192. https:\/\/doi.org\/10.5812\/ijcm-160657.","DOI":"10.5812\/ijcm-160657"},{"key":"1154_CR20","doi-asserted-by":"publisher","unstructured":"Saeidi M, Pasdar A, Rahmani F, Ghorbani A, Mottaghi N, Amerizadeh F. A prospective to regulatory role of miRnas on Wnt\/\u03b2-catenin signaling and its crosstalk to the other cellular pathways in tumorigenesis of glioblastoma by a systems biology approach. Int J Cancer Manag. 2025;18(1). https:\/\/doi.org\/10.5812\/ijcm-156834.","DOI":"10.5812\/ijcm-156834"},{"key":"1154_CR21","doi-asserted-by":"publisher","unstructured":"Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M. AI-Powered insights into drug resistance in gastric cancer: a path toward precision therapy. Iran J Pharm Res. 2025;24(1):e159954. https:\/\/doi.org\/10.5812\/ijpr-159954.","DOI":"10.5812\/ijpr-159954"},{"key":"1154_CR22","doi-asserted-by":"publisher","unstructured":"Yazdani F, Mottaghi-Dastjerdi N, Shahbazi B, Ahmadi K, Ghorbani A, Soltany-Rezaee-Rad M, et al. Identification of key genes and pathways involved in T-DM1-resistance in OE-19 esophageal cancer cells through bioinformatics analysis. Heliyon. 2024;10(18):e37451. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37451.","DOI":"10.1016\/j.heliyon.2024.e37451"},{"issue":"1","key":"1154_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12876-023-02891-4","volume":"23","author":"N Mottaghi-Dastjerdi","year":"2023","unstructured":"Mottaghi-Dastjerdi N, Ghorbani A, Montazeri H, Guzzi PH. A systems biology approach to pathogenesis of gastric cancer: gene network modeling and pathway analysis. BMC Gastroenterol. 2023;23(1):248. https:\/\/doi.org\/10.1186\/s12876-023-02891-4.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"1154_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0960327114532386","volume":"34","author":"N Mottaghi-Dastjerdi","year":"2015","unstructured":"Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, Roshandel G, Ebrahimifard F, Setayesh N. Identification of novel genes involved in gastric carcinogenesis by suppression subtractive hybridization. Hum Exp Toxicol. 2015;34(1):3\u201311. https:\/\/doi.org\/10.1177\/0960327114532386.","journal-title":"Hum Exp Toxicol"},{"key":"1154_CR25","unstructured":"Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, Roshandel G, Ebrahimifard F, Setayesh N. Gene expression profiling revealed overexpression of vesicle amine transport protein-1 (VAT-1) as a potential oncogene in gastric cancer. Indian J Biotechnol. 2016;15:161\u201365."},{"issue":"1","key":"1154_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2008-2231-22-14","volume":"22","author":"N Mottaghi-Dastjerdi","year":"2014","unstructured":"Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, Roshandel G, Ebrahimifard F, Setayesh N. Genome expression analysis by suppression subtractive hybridization identified overexpression of humanin, a target gene in gastric cancer chemoresistance. Daru J Pharm Sci. 2014;22(1):14. https:\/\/doi.org\/10.1186\/2008-2231-22-14.","journal-title":"Daru J Pharm Sci"},{"issue":"1","key":"1154_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/185035","volume":"2014","author":"M Soltany-Rezaee-Rad","year":"2014","unstructured":"Soltany-Rezaee-Rad M, Mottaghi-Dastjerdi N, Setayesh N, Roshandel G, Ebrahimifard F, Sepehrizadeh Z. Overexpression of FOXO3, MYD88, and GAPDH identified by suppression subtractive hybridization in esophageal cancer is associated with autophagy. Gastroenterol Res Pract. 2014;2014(1):1\u20138. https:\/\/doi.org\/10.1155\/2014\/185035.","journal-title":"Gastroenterol Res Pract"},{"key":"1154_CR28","doi-asserted-by":"publisher","unstructured":"Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M. Advancements and applications of artificial intelligence in Pharmaceutical Sciences: a comprehensive review. Iran J Pharm Res. 2024;23(1):e150510. https:\/\/doi.org\/10.5812\/ijpr-150510.","DOI":"10.5812\/ijpr-150510"},{"key":"1154_CR29","doi-asserted-by":"publisher","unstructured":"Farsiu N, Ghorbani A, Karbanowicz TP, Mottaghi-Dastjerdi N, Veltri P, Guzzi PH. Discovery of long non-coding RNAs in na\u00efve CD4+ T cells in response to initiating antiretroviral therapy at acute or chronic phase of HIV-1 infection. Acta Virol. 2024;68:- 2024. https:\/\/doi.org\/10.3389\/av.2024.11572.","DOI":"10.3389\/av.2024.11572"},{"issue":"6","key":"1154_CR30","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP v.2\u2014a server for in silico prediction of allergens. J Mol Model. 2014;20(6):2278. https:\/\/doi.org\/10.1007\/s00894-014-2278-5.","journal-title":"J Mol Model"},{"key":"1154_CR31","doi-asserted-by":"publisher","unstructured":"Sharma N, Naorem LD, Jain S, Raghava GPS. ToxinPred2: an improved method for predicting toxicity of proteins. Briefings Bioinf. 2022;23(5). https:\/\/doi.org\/10.1093\/bib\/bbac174.","DOI":"10.1093\/bib\/bbac174"},{"issue":"2","key":"1154_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/pharmaceutics13020142","volume":"13","author":"M Luchner","year":"2021","unstructured":"Luchner M, Reinke S, Milicic A. TLR agonists as vaccine adjuvants targeting cancer and infectious diseases. Pharmaceutics. 2021;13(2):142. https:\/\/doi.org\/10.3390\/pharmaceutics13020142.","journal-title":"Pharmaceutics"},{"key":"1154_CR33","doi-asserted-by":"publisher","first-page":"620972","DOI":"10.3389\/fimmu.2020.620972","volume":"11","author":"MB Mielcarska","year":"2021","unstructured":"Mielcarska MB, Bossowska-Nowicka M, Toka FN. Cell surface expression of endosomal toll-like receptors\u2014A necessity or a superfluous duplication? Front Immunol. 2021;11:620972. https:\/\/doi.org\/10.3389\/fimmu.2020.620972.","journal-title":"Front Immunol"},{"key":"1154_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4419-0901-5_2","volume-title":"Target pattern recognition in innate immunity","author":"S Bauer","year":"2009","unstructured":"Bauer S, M\u00fcller T, Hamm S. Pattern recognition by Toll-like receptors. In: Kishore U, editor. Target pattern recognition in innate immunity. New York, NY: Springer New York; 2009. p. 15\u201334."},{"issue":"1","key":"1154_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1953680","volume":"2017","author":"L Jiang","year":"2017","unstructured":"Jiang L, Liu G, Ni W, Zhang N, Jie J, Xie F, et al. The combination of MBP and BCG-Induced dendritic cell maturation through TLR2\/TLR4 promotes Th1 activation in vitro and vivo. Mediators Inflammation. 2017;2017(1):1\u201314. https:\/\/doi.org\/10.1155\/2017\/1953680.","journal-title":"Mediators Inflammation"},{"issue":"35","key":"1154_CR36","doi-asserted-by":"publisher","first-page":"11018","DOI":"10.1073\/pnas.1502026112","volume":"112","author":"KJ Koymans","year":"2015","unstructured":"Koymans KJ, Feitsma LJ, Brondijk TH, Aerts PC, Lukkien E, Lossl P, et al. Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3). Proc Natl Acad Sci USA. 2015;112(35):11018\u201323. https:\/\/doi.org\/10.1073\/pnas.1502026112.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1154_CR37","doi-asserted-by":"publisher","unstructured":"Su L, Athamna M, Wang Y, Wang J, Freudenberg M, Yue T, et al. Sulfatides are endogenous ligands for the TLR4\u2013MD-2 complex. Proc Natl Acad Sci USA. 2021;118(30):e2105316118. https:\/\/doi.org\/10.1073\/pnas.2105316118.","DOI":"10.1073\/pnas.2105316118"},{"issue":"2","key":"1154_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. The ClusPro web server for protein\u2013protein docking. Nat Protoc. 2017;12(2):255\u201378. https:\/\/doi.org\/10.1038\/nprot.2016.169.","journal-title":"Nat Protoc"},{"issue":"23","key":"1154_CR39","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue LC, Rodrigues JP, Kastritis PL, Bonvin AM, Vangone A. PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics. 2016;32(23):3676\u201378. https:\/\/doi.org\/10.1093\/bioinformatics\/btw514.","journal-title":"Bioinformatics"},{"issue":"24","key":"1154_CR40","doi-asserted-by":"publisher","first-page":"15507","DOI":"10.1080\/07391102.2023.2190411","volume":"41","author":"F Koohnavard","year":"2023","unstructured":"Koohnavard F, Ahmadi K, Eftekhar E, Edalatmanesh MA. Computational screening of FDA-approved drugs to identify potential aromatase receptor inhibitors for polycystic ovary syndrome. J Educ Chang Biomol Struct Dyn. 2023;41(24):15507\u201319. https:\/\/doi.org\/10.1080\/07391102.2023.2190411.","journal-title":"J Educ Chang Biomol Struct Dyn"},{"issue":"10","key":"1154_CR41","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1080\/07391102.2022.2069863","volume":"41","author":"B Shahbazi","year":"2023","unstructured":"Shahbazi B, Arab SS, Mafakher L, Azadmansh K, Teimoori-Toolabi L. Computational assessment of pigment epithelium-derived factor as an anti-cancer protein during its interaction with the receptors. J Educ Chang Biomol Struct Dyn. 2023;41(10):4575\u201391. https:\/\/doi.org\/10.1080\/07391102.2022.2069863.","journal-title":"J Educ Chang Biomol Struct Dyn"},{"key":"1154_CR42","doi-asserted-by":"publisher","unstructured":"Weng G, Wang E, Wang Z, Liu H, Zhu F, Li D, et al. HawkDock: a web server to predict and analyze the protein\u2013protein complex based on computational docking and MM\/GBSA. Nucleic Acids Res. 2019;47(W1):W322\u201330. https:\/\/doi.org\/10.1093\/nar\/gkz397.","DOI":"10.1093\/nar\/gkz397"},{"key":"1154_CR43","doi-asserted-by":"publisher","unstructured":"Nuryana I, Laksmi FA, Dewi KS, Akbar FR, Nurhayati N, R. Codon optimization of a gene encoding DNA polymerase from pyrococcus furiosus and its expression in Escherichia coli. J Genet Eng Biotechnol. 2023;21(1):129. https:\/\/doi.org\/10.1186\/s43141-023-00605-7.","DOI":"10.1186\/s43141-023-00605-7"},{"issue":"5","key":"1154_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5501\/wjv.v9.i5.67","volume":"9","author":"A Dominari","year":"2020","unstructured":"Dominari A, Hathaway Iii D, Pandav K, Matos W, Biswas S, Reddy G, et al. Thymosin alpha 1: a comprehensive review of the literature. WJV. 2020;9(5):67\u201378. https:\/\/doi.org\/10.5501\/wjv.v9.i5.67.","journal-title":"WJV"},{"issue":"1","key":"1154_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8197048","volume":"2019","author":"LE Meli\u021b","year":"2019","unstructured":"Meli\u021b LE, M\u0103rginean CO, M\u0103rginean CD, M\u0103rginean MO. The relationship between toll-like receptors and helicobacter pylori-related gastropathies: still a controversial topic. J Immunol Res. 2019;2019(1):1\u201310. https:\/\/doi.org\/10.1155\/2019\/8197048.","journal-title":"J Immunol Res"},{"key":"1154_CR46","doi-asserted-by":"publisher","unstructured":"Yin Z, Li M, Niu C, Yu M, Xie X, Haimiti G, et al. Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS). PLoS One. 2023;18(8):e0286358. https:\/\/doi.org\/10.1371\/journal.pone.0286358.","DOI":"10.1371\/journal.pone.0286358"},{"issue":"9","key":"1154_CR47","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/vaccines10091389","volume":"10","author":"M Hammed-Akanmu","year":"2022","unstructured":"Hammed-Akanmu M, Mim M, Osman AY, Sheikh AM, Behmard E, Rabaan AA, et al. Designing a Multi-Epitope vaccine against toxoplasma gondii: An immunoinformatics approach. Nato Adv Sci Inst Se. 2022;10(9):1389. https:\/\/doi.org\/10.3390\/vaccines10091389.","journal-title":"Nato Adv Sci Inst Se"},{"issue":"9","key":"1154_CR48","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz V, Paul S, Andreatta M, Marcatili P, Peters B, Nielsen M. NetMHCpan-4.0: improved peptide\u2013MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J Immunol. 2017;199(9):3360\u201368. https:\/\/doi.org\/10.4049\/jimmunol.1700893.","journal-title":"J Immunol"},{"issue":"1","key":"1154_CR49","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s42003-024-07292-1","volume":"7","author":"DF Marzella","year":"2024","unstructured":"Marzella DF, Crocioni G, Radusinovi\u0107 T, Lepikhov D, Severin H, Bodor DL, et al. Geometric deep learning improves generalizability of MHC-bound peptide predictions. Commun Biol. 2024;7(1):1661. https:\/\/doi.org\/10.1038\/s42003-024-07292-1.","journal-title":"Commun Biol"},{"issue":"21","key":"1154_CR50","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1080\/07391102.2023.2263213","volume":"42","author":"X Li","year":"2024","unstructured":"Li X, Wen H, Xiao X, Ren Z, Tan C, Fu C. Design of a novel multi-epitope vaccine candidate against endometrial cancer using immunoinformatics and bioinformatics approaches. J Educ Chang Biomol Struct Dyn. 2024;42(21):11521\u201337. https:\/\/doi.org\/10.1080\/07391102.2023.2263213.","journal-title":"J Educ Chang Biomol Struct Dyn"},{"issue":"1","key":"1154_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12859-023-05197-0","volume":"24","author":"H Motamedi","year":"2023","unstructured":"Motamedi H, Ari MM, Shahlaei M, Moradi S, Farhadikia P, Alvandi A, et al. Designing multi-epitope vaccine against important colorectal cancer (CRC) associated pathogens based on immunoinformatics approach. BMC Bioinf. 2023;24(1):65. https:\/\/doi.org\/10.1186\/s12859-023-05197-0.","journal-title":"BMC Bioinf"},{"issue":"11","key":"1154_CR52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368. https:\/\/doi.org\/10.1038\/s41577-020-0306-5.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1154_CR53","doi-asserted-by":"publisher","first-page":"2297453","DOI":"10.1080\/21645515.2023.2297453","volume":"20","author":"D Jeon","year":"2024","unstructured":"Jeon D, Hill E, McNeel DG. Toll-like receptor agonists as cancer vaccine adjuvants. Hum vaccines immunotherapeutics. 2024;20(1):2297453. https:\/\/doi.org\/10.1080\/21645515.2023.2297453.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"11","key":"1154_CR54","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.4049\/jimmunol.1800085","volume":"200","author":"BA Fensterheim","year":"2018","unstructured":"Fensterheim BA, Young JD, Luan L, Kleinbard RR, Stothers CL, Patil NK, et al. The TLR4 agonist monophosphoryl lipid a drives broad resistance to infection via dynamic reprogramming of macrophage metabolism. J Immunol. 2018;200(11):3777\u201389. https:\/\/doi.org\/10.4049\/jimmunol.1800085.","journal-title":"J Immunol"},{"issue":"1","key":"1154_CR55","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/14760584.2024.2382725","volume":"23","author":"F Roman","year":"2024","unstructured":"Roman F, Burny W, Ceregido MA, Laup\u00e8ze B, Temmerman ST, Warter L, et al. Adjuvant system AS01: from mode of action to effective vaccines. Expert Rev Vaccines. 2024;23(1):715\u201329. https:\/\/doi.org\/10.1080\/14760584.2024.2382725.","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"1154_CR56","doi-asserted-by":"publisher","first-page":"101751","DOI":"10.1016\/j.xcrm.2024.101751","volume":"5","author":"K Liu","year":"2024","unstructured":"Liu K, Kong L, Cui H, Zhang L, Xin Q, Zhuang Y, et al. Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy. Cell Rep Med. 2024;5(10):101751. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101751.","journal-title":"Cell Rep. Med"},{"issue":"1","key":"1154_CR57","doi-asserted-by":"publisher","first-page":"13960","DOI":"10.1038\/s41598-025-97160-7","volume":"15","author":"S Yao","year":"2025","unstructured":"Yao S, Huang Q, Zou Y, Liu T, Yang Y, Huang T, et al. The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study. Sci Rep. 2025;15(1):13960. https:\/\/doi.org\/10.1038\/s41598-025-97160-7.","journal-title":"Sci Rep"},{"key":"1154_CR58","unstructured":"Chakraborty S, Latheef SK, Munjal A, Tiwari R, Samad HA, Karthik K, et al. Cytotoxic T cells and cancer therapy. 2017."},{"key":"1154_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fimmu.2017.00204","volume":"8","author":"SL Bevington","year":"2017","unstructured":"Bevington SL, Cauchy P, Withers DR, Lane PJL, Cockerill PN. T cell receptor and cytokine signaling can function at different stages to establish and maintain transcriptional memory and enable T helper cell differentiation. Front Immunol. 2017;8:204. https:\/\/doi.org\/10.3389\/fimmu.2017.00204.","journal-title":"Front Immunol"},{"issue":"7","key":"1154_CR60","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13205-024-04022-6","volume":"14","author":"A Roy","year":"2024","unstructured":"Roy A, Swetha RG, Basu S, Biswas R, Ramaiah S, Anbarasu A. Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1. 3 Biotech. 3 Biotech. 2024;14(7):176. https:\/\/doi.org\/10.1007\/s13205-024-04022-6.","journal-title":"3 Biotech"},{"key":"1154_CR61","doi-asserted-by":"publisher","first-page":"101782","DOI":"10.1016\/j.biologicals.2024.101782","volume":"87","author":"R Biswas","year":"2024","unstructured":"Biswas R, Swetha RG, Basu S, Roy A, Ramaiah S, Anbarasu A. Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines. Biologicals. 2024;87:101782. https:\/\/doi.org\/10.1016\/j.biologicals.2024.101782.","journal-title":"Biologicals"},{"key":"1154_CR62","doi-asserted-by":"publisher","unstructured":"Kant R, Khan MS, Chopra M, Saluja D. Artificial intelligence-driven reverse vaccinology for Neisseria gonorrhoeae vaccine: prioritizing epitope-based candidates. Front Mol Biosci. 2024;11:- 2024. https:\/\/doi.org\/10.3389\/fmolb.2024.1442158.","DOI":"10.3389\/fmolb.2024.1442158"},{"issue":"19","key":"1154_CR63","doi-asserted-by":"publisher","first-page":"11437","DOI":"10.3390\/ijms231911437","volume":"23","author":"K-S Chang","year":"2022","unstructured":"Chang K-S, Chen S-T, Sung H-C, Hsu S-Y, Lin W-Y, Hou C-P, et al. WNT1 inducible signaling pathway protein 1 is a stroma-specific secreting protein inducing a fibroblast contraction and carcinoma cell growth in the human prostate. IJMS. 2022;23(19):11437. https:\/\/doi.org\/10.3390\/ijms231911437.","journal-title":"IJMS"},{"issue":"4","key":"1154_CR64","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.immuni.2024.03.015","volume":"57","author":"EC Lavelle","year":"2024","unstructured":"Lavelle EC, McEntee CP. Vaccine adjuvants: tailoring innate recognition to send the right message. Immunity. 2024;57(4):772\u201389. https:\/\/doi.org\/10.1016\/j.immuni.2024.03.015.","journal-title":"Immunity"},{"key":"1154_CR65","doi-asserted-by":"publisher","first-page":"109744","DOI":"10.1016\/j.intimp.2023.109744","volume":"117","author":"Y Wei","year":"2023","unstructured":"Wei Y, Zhang Y, Li P, Yan C, Wang L. Thymosin \u03b1-1 in cancer therapy: immunoregulation and potential applications. Int Immunopharmacol. 2023;117:109744. https:\/\/doi.org\/10.1016\/j.intimp.2023.109744.","journal-title":"Int Immunopharmacol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01154-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01154-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01154-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:07:58Z","timestamp":1786576078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12896-026-01154-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1186\/s12896-026-01154-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8247346\/v1","asserted-by":"object"}]},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animals, humans, or clinical data were not a part of this investigation.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"99"}}